Received Apr 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y019173 | LA |
raised, flat, red spots in a rash pattern on his abdomen; and his feet and hands were noticeably red; injection site on the left arm was noticeably red and appeared tender; raised, flat, red spots in a rash pattern on his abdomen; Viral reaction; injection site on the left arm was noticeably red and appeared tender; itching on his hands and feet; This spontaneous report was received from a consumer or other non-health professional and refers to a 4-year-old male patient (reporter's son). The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (Diphtheria vaccine toxoid;Pertussis vaccine acellular;Polio vaccine inact;Tetanus vaccine toxoid (DTAP/IPV) . On 31-Mar-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y019173, expiration date: 27-Jun-2024) 0.5 mL in left Arm, diluted with sterile diluent (MERCK STERILE DILUENT) (indication, expiration date, and lot # were not reported) for prophylaxis. On 02-Apr-2025 (also reported as this morning), the patient complained of itching on his hands and feet, and his feet and hands were noticeably red. The injection site on the left arm was noticeably red and appeared tender. He went to daycare as scheduled and was observed by his daycare teachers to behave normally all day, with continued reporting of his hands being itchy. Reporter reported these symptoms to his pediatric doctor, who advised her to keep an eye on it and schedule a follow up if we had concerns. In that evening reporter noted raised, flat, red spots in a rash pattern on his abdomen. The injection site on the left arm was more red and tender looking than in the morning. The rash did not seem to be making him uncomfortable, but she had a follow up virtual visit with his pediatrician to report the rash out of concern that it might be an allergic reaction to a vaccine component. The pediatrician advised that it did not appear to be an allergic reaction, but that it appeared to be a rash common with viral reactions. The pediatrician advised continued monitoring of the rash and to follow up if my son developed sores in or around his mouth or difficulty eating. At the reporting time, the outcome of the events was unknown. The causal relationship between all the events and Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) was not provided.
DTAP-IPV; Sterile diluent